Skip to content

Study · Case report or series · n = 1 · 1998

1 result

Emergence of an S gene mutant during thymosin alpha1 therapy in a patient with chronic hepatitis B.

Tang JH, Yeh CT, Chen TC, Hsieh SY, Chu CM, Liaw YF

The Journal of infectious diseases1 Sept 1998Cited by 14 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesOther

    In a patient with chronic hepatitis B treated with thymosin alpha1, an S gene mutant of hepatitis B virus emerged during therapy.

    In plain wordsIn one patient with hepatitis B treated with thymosin alpha‑1, a changed form of the virus appeared during treatment.

    Outcome
    Not applicableEmergence of hepatitis B virus S gene mutant during therapy
    Study

    n = 1

    Outcome group
    Antiviral activity · Infection
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In summary, an S gene mutant was identified in an HBsAg-seronegative patient.
    2 context sentences
    Summary · context
    The emergence of an S gene mutant during thymosin alpha1 treatment suggests that enhanced host immunity against HBsAg may play a role in its antiviral activity.
    Summary · context
    The presence of a hepatitis B virus S gene mutant was investigated in a patient being treated with thymosin alpha1.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.